In conclusion, our data provide strong evidence that IL6R haplotypes selectively regulate circulating levels of inflammatory biomarkers that constitute relevant indicators of cardiovascular risk but have a modest non significant effect on the risk of CHD. Here, IL6R is linked to coronary artery disorder.